TalhaMalikMDMSPH

PubMed

• Risankizumab Is Effective for the Management of Crohn's Disease of the Pouch.
  Tala B Shahin, Nowsherwan Khan, Talha A Malik
  Inflammatory Bowel Diseases. 2024-10-22
• The Unusual Clinical Presentation of Eosinophilic Gastroenteritis and Its Response to Mepolizumab: Two Case Reports.
  Mahmoud A Kiblawi, Talha Malik, Mazin M Edan
  Cureus. 2024-10-01
• Factors Associated With Short-Term Complications After Percutaneous Endoscopic Gastrostomy Tube Insertion: A Retrospective Cohort Study.
  Mostafa Shehata, Ibrahim Al Hosani, Ishtiaq Ahmed, Heba Abu Alkas, Omar Khaddam
  Cureus. 2024-03-01

Journal Articles

• Budesonide Use and Hospitalization Rate in Crohn's Disease: Results From a Cohort at a Tertiary Care IBD Referral Center  
  Orr J, Venkata KV, Young S, Xie F, Malik TA, J Clin Med Res, 1/1/2016
• Obesity and Outcome of Crohn's Associated Perianal Fistula Surgery: A Case-Control Study  
  Manne A, Khan A, Malik TA, Gastroenterology Research, 1/1/2015
• Body Mass Index is associated with Mucosal Disease in Crohn’s: Results of a Case-Control Study  
  Malik TA, Kaslow RA, Cofield SS, Mannon PJ., Gastroenterol Res., 7/1/2014
• Body Mass Index is associated with Mucosal Disease in Crohn's: Results of a Case-Control Study  
  Malik TA, Kaslow RA, Cofield SS, Mannon PJ, Gastroenterol Res, 1/1/2014
• Obesity is associated with Poor Surgical Outcome in Crohn’s Disease  
  Malik TA, Oster R, Inusah S, Eckhoff A, Manne A, Gutierrez A., Gastroenterol Res., 6/1/2013
• Obesity is associated with Poor Surgical Outcome in Crohn's Disease  
  Malik TA, Oster R, Inusah S, Eckhoff A, Manne A, Gutierrez A, Gastroenterol Res, 1/1/2013
• Correspondence Re: "Laparoscopic treatment of advanced colonic Cancer: a case-matched control with open surgery by Vignali et al" (CDI-00243-2013)  
  Malik TA, Colantonio L, McGwin G, Colorectal Dis, 1/1/2013
• Intake of trans fat and all-cause mortality in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) cohort  
  Kiage JN, Merrill PD, Robinson CJ, Cao Y, Malik TA, Hundley BC, Lao P, Judd SE, Cushman M, Howard VJ, Kabagambe EK, Am J Clin Nutr, 1/1/2013
• Chronic Recurrent Esophageal Diverticulitis - A Rare Entity  
  Manne A, Smith IB, Hatchett J, Juneau J, Kodali S, Malik TA, Weber FH, Gastroenterology Research, 1/1/2013
• Autoimmune hepatitis-primary sclerosing cholangitis overlap syndrome complicated by Crohn's disease  
  Malik TA, Gutierrez AM, McGuire B, Zarzour JG, Mukhtar F, Bloomer J, Digestion, 1/1/2010
• Case Report on Midgut Volvulus: Fellow's Corner  
  Gutierrez A, Malik TA, Practical Gastroenterology, 1/1/2009
• Join now to see all

Books/Book Chapters

• Handbook on the Management of Inpatient Inflammatory Bowel Disease’ 
  Chapter: Routine management of hospitalized patients with ulcerative colitis 
  Malik TA & Farraye FA2022
• Cecil Essentials of Medicine 
  Chapter: Inflammatory Bowel Disease 
  Malik TA & Farraye FAEdition 10,2021
• Inflammatory Bowel Disease: Epidemiology 
  Arora SS & Malik TAIntech Open Access2016
• Surgical Clinics of North America 
  Chapter: Inflammatory Bowel Disease: Historical Perspective, Epidemiology and Risk Factors. 
  Malik TA2015
• Frontiers in Bioscience S4 
  Chapter: Inflammatory bowel diseases: emerging therapies and promising molecular targets. 
  Malik TA, Mannon P2012
• Crohn's Disease- Management of Crohn's Disease: An Evidence Based Approach 
  Malik TAIntech Open Access2012
• Join now to see all

Abstracts/Posters

• Genetic Markers and Endoscopic Disease Activity in Crohn's Disease: Results from a Cohort at a Tertiary Care IBD Referral Center
  Arora SS, Venkata K, Xie F, Malik TA, Gastroenterology, 1/1/2017
• Genetic Markers and Endoscopic Disease Activity in Crohn's Disease: Results from a Cohort at a Tertiary Care IBD Referral Center.
  Arora SS, Venkata K, Xie F, Malik TA, Digestive Disease Week, Chicago, IL, 1/1/2017
• Genetic Markers and Radiological Disease Activity in Crohn's Disease: Results from a Cohort at a Tertiary Care IBD Referral Center.
  Arora SS, Venkata K, Xie F, Malik TA, ACG (American College of Gastroenterology), 1/1/2017
• "Comparative Effectiveness of Vedolizumab vs. Infliximab Induction Therapy in Ulcerative Colitis: Experience of a Real-World Cohort at a Tertiary IBD Center"
  Allamneni C, Venkata K, Yun H, Xie F, Deloach L, Malik TA, 2017 Crohns and Colitis Congress Meeting, 1/1/2017
• Genetic Markers and Radiological Disease Activity in Crohn's Disease: Results from a Cohort at a Tertiary Care IBD Referral Center
  Arora SS, Venkata K, Xie F, Malik TA, American Journal of Gastroenterology, 1/1/2017
• Budesonide Use and Hospitalization Rate in Crohn's Disease: Results from a Cohort at a Tertiary Care IBD Referral Center.
  Orr J, Venkata K, Xie F Malik TA, Gastroenterology, 1/1/2016
• Vaccination and Hospitalization Rate in Crohn's Disease: Results from a Cohort.
  Hoppmann N, Xie F, Malik TA, Digestive Disease Week, Chicago, IL, 1/1/2016
• Budesonide Use and Hospitalization Rate in Crohn's Disease: Results from a Cohort at a Tertiary Care IBD Referral Center.
  Orr J, Venkata K, Xie F Malik TA, Digestive Disease Week, Chicago, IL, 1/1/2016
• Vitamin D Level and Hospitalization Rate in Crohn's Disease: Results from a Cohort at a Tertiary Care IBD Referral Cente.
  Venkata K, Arora S, Xie F, Malik TA, Digestive Disease Week, Chicago, IL, 1/1/2016
• Socioeconomic Status and not Race Drives Hospitalization Rate among Crohn's Disease Patients: Results of a Cohort at a Tertiary Care IBD Center.
  Walker C, Kakati D, Fitzmorris P, Xie F, Malik TA, Digestive Disease Week, Chicago, IL, 1/1/2016
• Bone Mineral Density and Hospitalization Rate in Crohn's Disease: Results from a Cohort at a Tertiary Care IBD Referral Center.
  Venkata K, Arora SS, Xie F, Malik TA, ACG (American College of Gastroenterology), 1/1/2016
• Bone Mineral Density and Hospitalization Rate in Crohn's Disease: Results from a Cohort at a Tertiary Care IBD Referral Center.
  Venkata K, Arora SS, Xie F, Malik TA, American Journal of Gastroenterology, 1/1/2016
• Socioeconomic Status and not Race Drives Hospitalization Rate among Crohn's Disease Patients: Results of a Cohort at a Tertiary Care IBD Center.
  Walker C, Kakati D, Fitzmorris P, Xie F, Malik TA, Gastroenterology, 1/1/2016
• Vaccination and Hospitalization Rate in Crohn's Disease: Results from a Cohort.
  Hoppmann N, Xie F, Malik TA, Gastroenterology, 1/1/2016
• Vitamin D Level and Hospitalization Rate in Crohn's Disease: Results from a Cohort at a Tertiary Care IBD Referral Center.
  Venkata K, Arora S, Xie F, Malik TA, Gastroenterology, 1/1/2016
• Effect of Steroid Use on the Clinical Course of Crohn's Disease Patients with Metabolic Syndrome Followed at a Tertiary Care IBD Referral Center.
  Orr J, Young S, Walker C, Fitzmorris P, Xie F, Malik T, American Journal of Gastroenterology, 1/1/2015
• Impact of Non-Alcoholic Fatty Liver Disease on the Clinical Course of Crohn's Disease in Patients Followed at a Tertiary Care IBD Referral Center.
  Young S, Walker C, Orr J, Fitzmorris P, Xie F, Kodali S, Malik T, American Journal of Gastroenterology, 1/1/2015
• Impact of Statin Use on the Clinical Course of Crohn's Disease Patients with Non-alcoholic Fatty Liver Disease followed at a Tertiary Care IBD Referral Center.
  Walker C, Young S, Orr J, Xie F, Malik TA, American Journal of Gastroenterology, 1/1/2015
• Impact of Statin Use on the Clinical Course of Crohn's Disease Patients with Non-alcoholic Fatty Liver Disease followed at a Tertiary Care IBD Referral Center.
  Walker C, Young S, Orr J, Xie F, Malik TA, ACG (American College of Gastroenterology), 1/1/2015
• Impact of Non-Alcoholic Fatty Liver Disease on the Clinical Course of Crohn's Disease in Patients Followed at a Tertiary Care IBD Referral Center.
  Young S, Walker C, Orr J, Fitzmorris P, Xie F, Kodali S, Malik T, ACG (American College of Gastroenterology), 1/1/2015
• Effect of Steroid Use on the Clinical Course of Crohn's Disease Patients with Metabolic Syndrome Followed at a Tertiary Care IBD Referral Center.
  Orr J, Young S, Walker C, Fitzmorris P, Xie F, Malik T, ACG (American College of Gastroenterology), 1/1/2015
• Prevalence and Distribution of Metabolic Syndrome among Crohn's Disease Patients seen at a Tertiary IBD Referral Center.
  Fitzmorris P, Smith IB, Torrazza E, Blackburn B, Kakati D, Malik TA, Digestive Disease Week, Chicago, IL, 1/1/2014
• "Effect of BMI on Functional Status of Patients with Cirrhosis Based on the Six-Minute Walk Test."
  Juneau JE, Kodali S, Malik TA,Tsai WC, Booth JB, McGuire BM, Gastroenterology, 1/1/2014
• Impact of Metabolic Syndrome on the Clinical Course of Crohn's Disease Patients.
  Fitzmorris P, Smith IB, Torrazza E, Blackburn B, Kakati D, Malik, TA, Gastroenterology, 1/1/2014
• Prevalence and Distribution of Metabolic Syndrome among Crohn's Disease Patients seen at a Tertiary IBD Referral Center.
  Fitzmorris P, Smith IB, Torrazza E, Blackburn B, Kakati D, Malik, TA, Gastroenterology, 1/1/2014
• Join now to see all

Lectures

• Approach to Management of Crohns. 
  Children's Hospital, University of Alabama at Birmingham - 1/22/2017
• "Management of Crohns" 
  Hyatt Regency, Wynfrey Hotel - 1/8/2017
• Probiotics Prevent Hepatic Encephalopathy in Patients With Cirrhosis: A Randomized Controlled Trial Lunia et al. Clinical Gastroenterology and Hepatology. June 2014. 
  1/19/2014
• Hepatocellular Carcinoma 
  1/16/2014
• Morbidity and Mortality 
  1/12/2014
• Subcutaneous Golimumab Maintains ClinicalResponse in Patients With Moderate-to-Severe Ulcerative Colitis. Gastroenterology. 2014 Jan;146(1):96-109. Sandborn WJ and PUR... 
  1/9/2014
• Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis. Gastroenterology. 2014 Jan;146(1):85-95. Sandbor... 
  1/9/2014
• Adalimumab is more effective than azathioprine and mesalamine at preventing Post-operative recurrence of Crohn's disease: a randomized controlled trial. Savarino et al... 
  1/1/2014
• Early Administration of Azathioprine vs. Conventional Management of Crohn's Disease: A Randomized Controlled Trial. Cosnes et al. Gastroenterology September 2013. 
  1/24/2013
• A Prospective Study of Long-term Intake of Dietary Fiber and Risk of Crohn's Disease and Ulcerative Colitis by Ananthakrishnan et al accepted for Publication in Gastro... 
  1/15/2013
• Approach to Management of Ulcerative Colitis 
  1/14/2013
• Rescue Therapy with Cyclosporine or Infliximab is not associated with an Increased Risk for Post-operative Complications in Patients Hospitalized for Severe, Steroid-r... 
  1/12/2013
• Preventative Management/Health Maintenance in the IBD Patient 
  1/10/2013
• Management of Chronic Hepatitis C. 
  1/9/2013
• Sclerosing Mesenteritis- Approach to Diagnosis and Management. 
  1/5/2013
• Patient with Severe Fistulizing Ileocolonic Crohn's with Rheumatologic, Cutaneous, Ophthalmologic and Perianal Disease Manifestations Resistant to all Traditional Trea... 
  1/5/2013
• Epidemiology of Hepatocellular Carcinoma 
  1/5/2013
• Resistant Chronic Pouchitis in Patient with UC pancolitis s/p Total Proctocolectomy with Ileal-Pouch Anal Anastomosis and Recurrent Positive Stool Studies for Clostrid... 
  1/3/2013
• Eosinophilic Esophagitis and Esophageal Dysmotility Disorders-Approach to Diagnosis and Management 
  1/2/2013
• Primary Sclerosing Cholangitis 
  1/2/2013
• Accuracy Of Magnetic Resonance Enterography In Assessing Response To Therapy And Mucosal Healing In Patients With Crohn's Disease by Orda et al. October 2013 in Gastro... 
  1/1/2013
• Once-daily budesonide MMX® extended-release tablets induce remission in patients with mild to moderate ulcerative colitis: results from the CORE I study. Sandborn et a... 
  1/1/2013
• Approach to Management of Perianal Crohn's Disease 
  1/12/2012
• Prevalence of Colorectal Cancer Associated with Streptococcus bovis among Inflammatory Bowel and Chronic Gastrointestinal Tract Disease Patients 
  1/9/2012
• Approach to Management of Crohn's Disease. 
  1/5/2012
• Join now to see all